NRx Pharmaceuticals
Mr. Pines previously served as Associate Commissioner of the US Food and Drug Administration.
This person is not in the org chart
This person is not in any offices
NRx Pharmaceuticals
NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.